Resveratrol as a pan-HDAC inhibitor alters the acetylation status of histone [corrected] proteins in human-derived hepatoblastoma cells.
The polyphenolic alcohol resveratrol has demonstrated promising activities for the prevention and treatment of cancer. Different modes of action have been described for resveratrol including the activation of sirtuins, which represent the class III histone deacetylases (HDACs). However, little is kn...
Guardado en:
Autores principales: | Sascha Venturelli, Alexander Berger, Alexander Böcker, Christian Busch, Timo Weiland, Seema Noor, Christian Leischner, Sabine Schleicher, Mascha Mayer, Thomas S Weiss, Stephan C Bischoff, Ulrich M Lauer, Michael Bitzer |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2013
|
Materias: | |
Acceso en línea: | https://doaj.org/article/41577d7486b646e0851eb802fa7d4597 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Hepcidin is regulated by promoter-associated histone acetylation and HDAC3
por: Sant-Rayn Pasricha, et al.
Publicado: (2017) -
Unresectable hepatoblastoma: current perspectives
por: Trobaugh-Lotrario AD, et al.
Publicado: (2017) -
Vitamins as Possible Cancer Biomarkers: Significance and Limitations
por: Sascha Venturelli, et al.
Publicado: (2021) -
Activation of p21 by HDAC inhibitors requires acetylation of H2A.Z.
por: Luca Bellucci, et al.
Publicado: (2013) -
Selective protection of human liver tissue in TNF-targeting of cancers of the liver by transient depletion of adenosine triphosphate.
por: Timo Weiland, et al.
Publicado: (2012)